Derek J. Royer - Concepedia

Author

Derek J. Royer

University of Oklahoma Health Sciences Center ORCID

Also Known As

D J Royer, D. Royer, Derek J Royer, Derek J. Royer, Derek Royer

Publications

501

Citations

H-Index

Concepts

All Affiliations

University of Oklahoma Health Sciences Center Southern Illinois University School of Medicine The University of Texas Southwestern Medical Center

About

Derek J. Royer is an author at University of Oklahoma Health Sciences Center specializing in immunology, medicine, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	261
2	Immunology	7	7	261
3	Social Sciences	1	1	86
4	Allergy	1	1	46
5	Neurology	1	1	86

Derek J. Royer

Publications

481

Citations

H-Index

Page 1

	Year	Citations
Microglia and a Functional Type I IFN Pathway Are Required To Counter HSV-1–Driven Brain Lateral Ventricle Enlargement and Encephalitis Christopher D. Conrady, Min Zheng, Nico van Rooijen, The Journal of Immunology ImmunologyViral PathogenesisMortality RatesSocial SciencesSimilar Enlargement	2013	86
Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages* Derek J. Royer, James N. George, Deirdra R. Terrell European Journal Of Haematology	2010	54
Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils Derek J. Royer, Min Zheng, Christopher D. Conrady, Investigative Ophthalmology & Visual Science	2015	49
A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin Derek J. Royer, Daniel J.J. Carr Mucosal Immunology Host ResponseHsv-1 InfectionMedicinePathogenesisViral Pathogenesis	2015	47
Complement and CD4+ T cells drive context-specific corneal sensory neuropathy Derek J. Royer, Jose Echegaray-Mendez, Liwen Lin, eLife ImmunologyImmune RegulationImmunologic MechanismDermatologyImmunotherapy	2019	46
A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity Derek J. Royer, Hem R. Gurung, Jeremy K. Jinkins, Journal of Virology	2016	37
Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection Derek J. Royer, Joshua F. Hendrix, Chelsea M. Larabee, Mucosal Immunology ImmunologyImmune SystemImmunotherapyParenteral VaccinationVaccine Target	2019	27
The current state of vaccine development for ocular HSV-1 infection Derek J. Royer, Alex W. Cohen, Daniel J.J. Carr Expert Review of Ophthalmology VaccinationVaccine DevelopmentVaccine TargetVaccine SurveillanceImmunology	2015	23
The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa Derek J. Royer, Meghan M. Carr, Hem R. Gurung, The Journal of Immunology Humoral ResponseImmunologyImmunodominanceViral InfectionImmunotherapeutics	2017	19
Corneal Epithelial Cells Exhibit Myeloid Characteristics and Present Antigen via MHC Class II Derek J. Royer, Michael H. Elliott, Yun Le, Investigative Ophthalmology & Visual Science	2018	18

Page 1